CVRx, Inc. Common Stock

Go to CVRx, Inc. Common Stock Website

$6.80

-0.75 (-9.87%)
Live
Previous Close

$6.805

Day Range

$6.15 - $7.5673

Previous Day Range

$7.495 - $7.865

Market Cap

$196.8 million USD

Day Vol.

777875

Previous Day Vol.

279751

Currency

USD

Primary Exchange

Nasdaq

CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is ...


Community
  • 0 posts discussing
0

Watchers

0

Visitors


Recent News

CVRx's Barostim device has demonstrated significant reductions in hospital visits and length of stay for heart failure patients, according to new real-world evidence presented at the THT 2025 conference and published in the Journal of Cardiac Failure.

Related tickers: CVRX.

Read Full Article

CVRx, a medical device company, announced that it will present at the 43rd Annual J.P. Morgan Healthcare Conference on January 15, 2025. The company's Barostim System, which uses neuromodulation to improve heart failure symptoms, has received FDA approval and the CE Mark in the European Economic Area.

Related tickers: CVRX.

Read Full Article
Trending Tickers

Please sign in to view